#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J. Clin. 2020;70.",Cancer statistics,CA Cancer J. Clin,2020,70,,,,,Siegel RL; Miller KD; Jemal A
2,"Morgensztern D, Waqar S, Subramanian J, Grgao F. Improving survival for stage IV non-small cell lung cancer: A Surveillance, Epidemiology, and End Results survey from 1990 to 2005. J. Thorac. Oncol. 2009;4. doi:10.1097/JTO.0b013e3181ba3634.","Improving survival for stage IV non-small cell lung cancer: A Surveillance, Epidemiology, and End Results survey from 1990 to 2005",J. Thorac. Oncol,2009,4,,,10.1097/JTO.0b013e3181ba3634,,Morgensztern D; Waqar S; Subramanian J; Grgao F
3,"Varlotto JM, Emmerick I, Voland R et al.. The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management. Front. Oncol. 2020;10:417. doi:10.3389/fonc.2020.00417.",The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management,Front. Oncol,2020,10,,417,10.3389/fonc.2020.00417,,Varlotto JM; Emmerick I; Voland R; Decamp MM; Flickinger JC; Maddox DJ; Herbert C; Griffin M; Rava P; Fitzgerald TJ
4,"Reck M, Rabe KF. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. N. Engl. J. Med. 2017;377. doi:10.1056/NEJMra1703413.",Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer,N. Engl. J. Med,2017,377,,,10.1056/NEJMra1703413,,Reck M; Rabe KF
5,"Agostinis P, Berg K, Cengel KA et al.. Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 2011;61. doi:10.3322/caac.20114.",Photodynamic therapy of cancer: An update,CA Cancer J. Clin,2011,61,,,10.3322/caac.20114,,Agostinis P; Berg K; Cengel KA; Foster TH; Girotti AW; Gollnick SO; Hahn SM; Hamblin MR; Juzeniene A; Kessel D
6,"Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris DJ, Alberts WM. Execuative Summary-Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2013;143. doi:10.1378/chest.12-2377.","Execuative Summary-Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines",Chest,2013,143,,,10.1378/chest.12-2377,,Detterbeck FC; Lewis SZ; Diekemper R; Addrizzo-Harris DJ; Alberts WM
7,"Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nature. 2003;3. doi:10.1038/nrc1071.",Photodynamic therapy for cancer,Nature,2003,3,,,10.1038/nrc1071,,Dolmans DE; Fukumura D; Jain RK
8,"Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003;43. doi:10.1016/S0169-5002(03)00152-1.",The role of radiotherapy in treatment of stage I non-small cell lung cancer,Lung Cancer,2003,43,,,10.1016/S0169-5002(03)00152-1,,Qiao X; Tullgren O; Lax I; Sirzen F; Lewensohn R
9,"Shafirstein G, Battoo A, Harris K et al.. Photodynamic Therapy of Non-Small Cell Lung Cancer Narrative Review and Future Directions. Ann. Am. Thorac. Soc. 2016;13. doi:10.1513/AnnalsATS.201509-650FR.",Photodynamic Therapy of Non-Small Cell Lung Cancer Narrative Review and Future Directions,Ann. Am. Thorac. Soc,2016,13,,,10.1513/AnnalsATS.201509-650FR,,Shafirstein G; Battoo A; Harris K; Baumann H; Gollnick SO; Lindenmann J; Nwogu CE
10,"Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha H. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax. 2004;59. doi:10.1136/thx.2003.013599.",Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma,Thorax,2004,59,,,10.1136/thx.2003.013599,,Freitag L; Ernst A; Thomas M; Prenzel R; Wahlers B; Macha H
11,"Lam S, Grafton C, Coy P, Voss N, Fairey R. Combinedphotodynamic therapy (PDT) using photofrin and radiother-apy (XRT) versus radiotherapy alone in patients with inop-erable obstructive non-small cell bronchogenic carcinoma. SPIE. 1991;1616.",Combinedphotodynamic therapy (PDT) using photofrin and radiother-apy (XRT) versus radiotherapy alone in patients with inop-erable obstructive non-small cell bronchogenic carcinoma,SPIE,1991,1616,,,,,Lam S; Grafton C; Coy P; Voss N; Fairey R
12,"Allison R, Moghissi K, Downie G, Dixon K. Photodynamic therapy (PDT) for lung cancer. Photodiagn. Photodyn. 2011;8. doi:10.1016/j.pdpdt.2011.03.342.",Photodynamic therapy (PDT) for lung cancer,Photodiagn. Photodyn,2011,8,,,10.1016/j.pdpdt.2011.03.342,,Allison R; Moghissi K; Downie G; Dixon K
13,"Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin. Proc. 1997;72. doi:10.1016/S0025-6196(11)63563-5.",Photodynamic therapy for early stage squamous cell carcinoma of the lung,Mayo Clin. Proc,1997,72,,,10.1016/S0025-6196(11)63563-5,,Cortese DA; Edell ES; Kinsey JH
14,"Corti L, Toniolo L, Boso C et al.. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg. Med. 2007;39.",Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma,Lasers Surg. Med,2007,39,,,,,Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L
15,"Moghissi K, Dixon K, Thorpe JA, Stringer M. Photodynamic therapy (PDT) in early central lung cancer: A treatment option for patients ineligible for surgical resection. Thorax. 2007;62. doi:10.1136/thx.2006.061143.",Photodynamic therapy (PDT) in early central lung cancer: A treatment option for patients ineligible for surgical resection,Thorax,2007,62,,,10.1136/thx.2006.061143,,Moghissi K; Dixon K; Thorpe JA; Stringer M
16,"Simone CB, Friedberg JS, Glatstein E et al.. Photodynamic therapy for the treatment of non-small cell lung cancer. J. Thorac. Dis. 2011;4.",Photodynamic therapy for the treatment of non-small cell lung cancer,J. Thorac. Dis,2011,4,,,,,Simone CB; Friedberg JS; Glatstein E; Stevenson JP; Sterman DH; Hahn SM; Cengel KA
17,"Usuda J, Kato H, Okunaka T et al.. Photodynamic Therapy (PDT) for Lung Cancers. J. Thorac. Oncol. 2006;1. doi:10.1016/S1556-0864(15)31616-6.",Photodynamic Therapy (PDT) for Lung Cancers,J. Thorac. Oncol,2006,1,,,10.1016/S1556-0864(15)31616-6,,Usuda J; Kato H; Okunaka T; Furukawa K; Tsutsui H; Yamada K; Suga Y; Honda H; Nagatsuka Y; Ohira T
18,"Hanna N, Johnson D, Temin S et al.. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update. J. Clin. Oncol. 2017;35.",Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update,J. Clin. Oncol,2017,35,,,,,Hanna N; Johnson D; Temin S; Baker S; Jr; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB
19,"Gomez DR, Blumenschein GR, Jr et al.. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17. doi:10.1016/S1470-2045(16)30532-0.","Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study",Lancet Oncol,2016,17,,,10.1016/S1470-2045(16)30532-0,,Gomez DR; Blumenschein GR; Jr; Lee JJ; Hernandez M; Ye R; Camidge DR; Doebele RC; Skoulidis F; Gaspar LE; Gibbons DL
20,"Jayadevappa R, Chhatre S, Soukiasian HJ, Murgu S. Outcomes of patients with advanced non-small cell lung cancer and airway obstruction treated with photodynamic therapy and non-photodynamic therapy ablation modalities. J. Thorac. Dis. 2019;11. doi:10.21037/jtd.2019.04.60.",Outcomes of patients with advanced non-small cell lung cancer and airway obstruction treated with photodynamic therapy and non-photodynamic therapy ablation modalities,J. Thorac. Dis,2019,11,,,10.21037/jtd.2019.04.60,,Jayadevappa R; Chhatre S; Soukiasian HJ; Murgu S
21,"Reginato E, Lindenmann J, Langner C et al.. Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma. Photochem. Photobiol. Sci. 2014;13. doi:10.1039/C4PP00186A.",Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma,Photochem. Photobiol. Sci,2014,13,,,10.1039/C4PP00186A,,Reginato E; Lindenmann J; Langner C; Schweintzger N; Bambach I; Smolle-JÃ¼ttner F; Wolf P
22,"Reynders K, Illidge T, Siva S, Chang JY, De Ruyssche D. The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant. Cancer Treat. Rev. 2015;41. doi:10.1016/j.ctrv.2015.03.011.",The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant,Cancer Treat. Rev,2015,41,,,10.1016/j.ctrv.2015.03.011,,Reynders K; Illidge T; Siva S; Chang JY; De Ruyssche D
23,"Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol. Res. 2010;46. doi:10.1007/s12026-009-8119-4.",Enhancement of anti-tumor immunity by photodynamic therapy,Immunol. Res,2010,46,,,10.1007/s12026-009-8119-4,,Gollnick SO; Brackett CM
24,"Lindenmann J, Matzi V, Neubock N, Maier A, Smolle-Juttner FM. The clinical impact of photodynamic therapy in thoracic surgery. Eur. Surg. 2010;42. doi:10.1007/s10353-010-0559-5.",The clinical impact of photodynamic therapy in thoracic surgery,Eur. Surg,2010,42,,,10.1007/s10353-010-0559-5,,Lindenmann J; Matzi V; Neubock N; Maier A; Smolle-Juttner FM
25,"Maier A, Tomaselli F, Matzi V et al.. Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: A clinical pilot study. Lasers Surg. Med. 2002;30. doi:10.1002/lsm.10009.",Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: A clinical pilot study,Lasers Surg. Med,2002,30,,,10.1002/lsm.10009,,Maier A; Tomaselli F; Matzi V; Woltsche M; Anegg U; Fell B; Rehak P; Pinter H; Smolle-JÃ¼ttner FM
26,"Bhalla N, Brooker R, Brada M. Combining immunotherapy and radiotherapy in lung cancer. J. Thorac. Dis. 2018;10. doi:10.21037/jtd.2018.05.107.",Combining immunotherapy and radiotherapy in lung cancer,J. Thorac. Dis,2018,10,,,10.21037/jtd.2018.05.107,,Bhalla N; Brooker R; Brada M
27,"Uhlig J, Case MD, Blasberg JD et al.. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer. JAMA Netw. Open. 2019;2:199702. doi:10.1001/jamanetworkopen.2019.9702.",Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer,JAMA Netw. Open,2019,2,,199702,10.1001/jamanetworkopen.2019.9702,,Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
28,Boffa DJ. The objective of local therapy in oligometastatic cancer is amoving target. JAMA Oncol. 1296;4.,The objective of local therapy in oligometastatic cancer is amoving target,JAMA Oncol,1296,4,,,,,Boffa DJ
29,"Iyengar P, Kavanagh BD, Wardak Z et al.. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressivemetastatic non-small-cell lung cancer. J. Clin. Oncol. 2014;32. doi:10.1200/JCO.2014.56.7412.",Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressivemetastatic non-small-cell lung cancer,J. Clin. Oncol,2014,32,,,10.1200/JCO.2014.56.7412,,Iyengar P; Kavanagh BD; Wardak Z; Smith I; Ahn C; Gerber DE; Dowell J; Hughes R; Abdulrahman R; Camidge DR
30,"Harris JP, Murphy JD, Hanlon AL et al.. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2014;88. doi:10.1016/j.ijrobp.2013.12.010.",A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer,Int. J. Radiat. Oncol. Biol. Phys,2014,88,,,10.1016/j.ijrobp.2013.12.010,,Harris JP; Murphy JD; Hanlon AL; Le Q; Loo BW; Jr; Diehn M
31,"Davidoff AJ, Tang M, Seal B, Edelman MJ. Chemotherapy and survival benefit in elderly patients with advanced non-smallcell lung cancer. J. Clin. Oncol. 2010;28. doi:10.1200/JCO.2009.25.4052.",Chemotherapy and survival benefit in elderly patients with advanced non-smallcell lung cancer,J. Clin. Oncol,2010,28,,,10.1200/JCO.2009.25.4052,,Davidoff AJ; Tang M; Seal B; Edelman MJ
32,"Salazar MC, Rosen JE, Arnold BN et al.. Adjuvant Chemotherapy for T3 Non-Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe. J. Thorac. Oncol. 2016;11. doi:10.1016/j.jtho.2016.03.009.",Adjuvant Chemotherapy for T3 Non-Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe,J. Thorac. Oncol,2016,11,,,10.1016/j.jtho.2016.03.009,,Salazar MC; Rosen JE; Arnold BN; Thomas DC; Kim AW; Detterbeck FC; Blasberg JD; Boffa DJ
33,"Ramnath N, Dilling TJ, Harris LJ et al.. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143. doi:10.1378/chest.12-2360.","Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines",Chest,2013,143,,,10.1378/chest.12-2360,,Ramnath N; Dilling TJ; Harris LJ; Kim AW; Michaud GC; Balekian AA; Diekemper R; Detterbeck FC
34,"Bott MJ, Patel AP, Crabtree TD et al.. Role for Surgical Resection in the Multi-Disciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer. Ann. Thorac. Surg. 2015;99. doi:10.1016/j.athoracsur.2015.02.033.",Role for Surgical Resection in the Multi-Disciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer,Ann. Thorac. Surg,2015,99,,,10.1016/j.athoracsur.2015.02.033,,Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA
35,"Postmus PE, Kerr KM, Oudkerk M et al.. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Clinical Practice Guidelines. Ann. Oncol. 2017;28.","Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Clinical Practice Guidelines",Ann. Oncol,2017,28,,,,,Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S
36,"Iocolanoa M, Wildb AT, Hannumc M et al.. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy. Acta Oncol. 2020;59. doi:10.1080/0284186X.2019.1675907.",Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy,Acta Oncol,2020,59,,,10.1080/0284186X.2019.1675907,,Iocolanoa M; Wildb AT; Hannumc M; Zhangc Z; Simone II; Gelblumb D; Wub AJ; Shepherdb AF
37,"Warren JL, Klabunder CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data-content, research application and generalizability to the United States elderly population. Med. Care. 2002;40. doi:10.1097/00005650-200208001-00002.","Overview of the SEER-Medicare data-content, research application and generalizability to the United States elderly population",Med. Care,2002,40,,,10.1097/00005650-200208001-00002,,Warren JL; Klabunder CN; Schrag D; Bach PB; Riley GF
38,"Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data-an overview. Med. Care. 2002;40(4). doi:10.1097/00005650-200208001-00004.",Assessing comorbidity using claims data-an overview,Med. Care,2002,40,4,,10.1097/00005650-200208001-00004,,Klabunde CN; Warren JL; Legler JM
39,"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 1992;45. doi:10.1016/0895-4356(92)90133-8.",Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases,J. Clin. Epidemiol,1992,45,,,10.1016/0895-4356(92)90133-8,,Deyo RA; Cherkin DC; Ciol MA
40,"Ladha KS, Zhao K, Quraishi SA et al.. Comorbidity Indices as predictors of mortality in critically ill patients. BMJ Open. 2015;5:8990. doi:10.1136/bmjopen-2015-008990.",Comorbidity Indices as predictors of mortality in critically ill patients,BMJ Open,2015,5,,8990,10.1136/bmjopen-2015-008990,,Ladha KS; Zhao K; Quraishi SA; Kurth T; Eikermann M; Kaafarani HM; Klein EN; Seethala R; Lee JT; Deyo-Charlson; Elixhauser-Van Walraven
41,"Melisa L, Wong ML, Mcmurry TL et al.. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03. J. Oncol. Pract. 2018;14.","Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03",J. Oncol. Pract,2018,14,,,,,Melisa L; Wong ML; Mcmurry TL; Schumacher Hu C; Stukenborg GJ; Francescatti AB; Greenberg CC; Chang GJ; Mckellar DP; Walter LC
